Comparison of Hydrogel-Based Autologous Chondrocyte Implantation Versus Microfracture: A Propensity Score Matched-Pair Analysis

Overview

Journal Orthop J Sports Med

Specialty Orthopedics

Date 2023 Sep 1

PMID 37655236

Authors

Philipp Niemeyer

Peter Angele

Robert C Spiro

Alexandra Kirner

Christoph Gaissmaier

Affiliations

Soon will be listed here.

Abstract

Background: Few studies exist for large defects comparing matrix-associated autologous chondrocyte implantation (M-ACI) with other cartilage repair methods due to the limited availability of suitable comparator treatments.

Purpose: To compare the clinical efficacy of a novel hydrogel-based M-ACI method (NOVOCART Inject plus) versus microfracture (MFx) in patients with knee cartilage defects.

Study Design: Cohort study; Level of evidence, 3.

Methods: Propensity score matched-pair analysis was used to compare the 24-month outcomes between the M-ACI treatment group from a previous single-arm phase 3 study and the MFx control group from another phase 3 study. Patients were matched based on preoperative Knee injury and Osteoarthritis Outcomes Score (KOOS), symptom duration, previous knee surgeries, age, and sex, resulting in 144 patients in the matched-pair set (72 patients per group). The primary endpoint was the change in least-squares means (Δ) for the KOOS from baseline to the 24-month assessment.

Results: Defect sizes in the M-ACI group were significantly larger than in the MFx group (6.4 versus 3.7 cm). Other differences included defect location (no patellar or tibial defects in the MFx group), number of defects (33.3% with 2 defects in the M-ACI group versus 9.7% in the MFx group), and defect cause (more patients with degenerative lesions in the M-ACI group). The M-ACI group had higher posttreatment KOOS (M-ACI versus MFX: 81.8 ± 16.8 versus 73.0 ± 20.6 points) and KOOS Δ from baseline to 24 months posttreatment (M-ACI versus MFX: 36.9 versus 26.9 points). Treatment contrasts in KOOS Δ from baseline indicated statistical significance in favor of M-ACI from 3 to 24 months posttreatment ( = .0026). Significant and clinically meaningful differences in favor of M-ACI at 24 months were also found regarding International Knee Documentation Committee (IKDC) score Δ from baseline (37.8 versus 30.4 points; = .0334), KOOS responder rates at 24 months (≥10-point improvement from baseline; 94.4% versus 65.3%; < .0001), IKDC responder rates at 24 months (>20.5-point improvement from baseline; 83.3% versus 61.1%, = .0126) and MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) score in a subgroup of patients (LS means, 86.9 versus 69.1; = .0096).

Conclusion: In this exploratory analysis, M-ACI using an in situ crosslinked hydrogel demonstrated superior clinical and structural (MOCART) 24-month outcomes compared with MFx in patients with knee cartilage defects.

Citing Articles

Favourable clinical outcomes and low revision rate after M-ACI in adolescents with immature cartilage compared to adult controls: Results at 10 years.

Weishorn J, Wiegand J, Koch K, Trefzer R, Renkawitz T, Walker T Knee Surg Sports Traumatol Arthrosc. 2024; 33(1):167-176.

PMID: 39010715 PMC: 11716355. DOI: 10.1002/ksa.12359.

Hydrogel-Based Matrix-Associated Autologous Chondrocyte Implantation Shows Greater Substantial Clinical Benefit at 24 Months Follow-Up than Microfracture: A Propensity Score Matched-Pair Analysis.

Gaissmaier C, Angele P, Spiro R, Kohler A, Kirner A, Niemeyer P Cartilage. 2024; :19476035241235928.

PMID: 38501741 PMC: 11569661. DOI: 10.1177/19476035241235928.

References

Harris J, Brophy R, Siston R, Flanigan D . Treatment of chondral defects in the athlete's knee. Arthroscopy. 2010; 26(6):841-52. DOI: 10.1016/j.arthro.2009.12.030. View

Marlovits S, Singer P, Zeller P, Mandl I, Haller J, Trattnig S . Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: determination of interobserver variability and correlation to clinical outcome after 2 years. Eur J Radiol. 2005; 57(1):16-23. DOI: 10.1016/j.ejrad.2005.08.007. View

Brown W, Potter H, Marx R, Wickiewicz T, Warren R . Magnetic resonance imaging appearance of cartilage repair in the knee. Clin Orthop Relat Res. 2004; (422):214-23. DOI: 10.1097/01.blo.0000129162.36302.4f. View

Abraamyan T, Johnson A, Wiedrick J, Crawford D . Marrow Stimulation Has Relatively Inferior Patient-Reported Outcomes in Cartilage Restoration Surgery of the Knee: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2021; 50(3):858-866. DOI: 10.1177/03635465211003595. View

Marechal M, Van Hauwermeiren H, Neys J, Vanderlinden G, van de Putte T . In Vivo Evaluation of Different Surgical Procedures for Autologous Chondrocyte Implantation. Cartilage. 2015; 4(1):83-90. PMC: 4297110. DOI: 10.1177/1947603512457564. View

Niemeyer P, Albrecht D, Aurich M, Becher C, Behrens P, Bichmann P . Empfehlungen der AG Klinische Geweberegeneration zur Behandlung von Knorpelschäden am Kniegelenk. Z Orthop Unfall. 2022; 161(1):57-64. DOI: 10.1055/a-1663-6807. View

Hunziker E, Stahli A . Surgical suturing of articular cartilage induces osteoarthritis-like changes. Osteoarthritis Cartilage. 2008; 16(9):1067-73. PMC: 2657041. DOI: 10.1016/j.joca.2008.01.009. View

Stuart E . Matching methods for causal inference: A review and a look forward. Stat Sci. 2010; 25(1):1-21. PMC: 2943670. DOI: 10.1214/09-STS313. View

Saris D, Vanlauwe J, Victor J, Haspl M, Bohnsack M, Fortems Y . Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med. 2008; 36(2):235-46. DOI: 10.1177/0363546507311095. View

10.

Oussedik S, Tsitskaris K, Parker D . Treatment of articular cartilage lesions of the knee by microfracture or autologous chondrocyte implantation: a systematic review. Arthroscopy. 2015; 31(4):732-44. DOI: 10.1016/j.arthro.2014.11.023. View

11.

Gobbi A, Karnatzikos G, Kumar A . Long-term results after microfracture treatment for full-thickness knee chondral lesions in athletes. Knee Surg Sports Traumatol Arthrosc. 2013; 22(9):1986-96. DOI: 10.1007/s00167-013-2676-8. View

12.

Niemeyer P, Albrecht D, Andereya S, Angele P, Ateschrang A, Aurich M . Autologous chondrocyte implantation (ACI) for cartilage defects of the knee: A guideline by the working group "Clinical Tissue Regeneration" of the German Society of Orthopaedics and Trauma (DGOU). Knee. 2016; 23(3):426-35. DOI: 10.1016/j.knee.2016.02.001. View

13.

Lynch T, Patel R, Benedick A, Amin N, Jones M, Miniaci A . Systematic review of autogenous osteochondral transplant outcomes. Arthroscopy. 2015; 31(4):746-54. DOI: 10.1016/j.arthro.2014.11.018. View

14.

Everhart J, Campbell A, Abouljoud M, Kirven J, Flanigan D . Cost-efficacy of Knee Cartilage Defect Treatments in the United States. Am J Sports Med. 2019; 48(1):242-251. DOI: 10.1177/0363546519834557. View

15.

Hirschmuller A, Baur H, Braun S, Kreuz P, Sudkamp N, Niemeyer P . Rehabilitation after autologous chondrocyte implantation for isolated cartilage defects of the knee. Am J Sports Med. 2011; 39(12):2686-96. DOI: 10.1177/0363546511404204. View

16.

Niethammer T, Gallik D, Chevalier Y, Holzgruber M, Baur-Melnyk A, Muller P . Effect of the defect localization and size on the success of third-generation autologous chondrocyte implantation in the knee joint. Int Orthop. 2020; 45(6):1483-1491. PMC: 8178140. DOI: 10.1007/s00264-020-04884-4. View

17.

Schneider U, Rackwitz L, Andereya S, Siebenlist S, Fensky F, Reichert J . A prospective multicenter study on the outcome of type I collagen hydrogel-based autologous chondrocyte implantation (CaReS) for the repair of articular cartilage defects in the knee. Am J Sports Med. 2011; 39(12):2558-65. DOI: 10.1177/0363546511423369. View

18.

Ebert J, Smith A, Fallon M, Wood D, Ackland T . Correlation Between Clinical and Radiological Outcomes After Matrix-Induced Autologous Chondrocyte Implantation in the Femoral Condyles. Am J Sports Med. 2014; 42(8):1857-64. DOI: 10.1177/0363546514534942. View

19.

Biant L, McNicholas M, Sprowson A, Spalding T . The surgical management of symptomatic articular cartilage defects of the knee: Consensus statements from United Kingdom knee surgeons. Knee. 2015; 22(5):446-9. DOI: 10.1016/j.knee.2015.06.001. View

20.

Pestka J, Feucht M, Porichis S, Bode G, Sudkamp N, Niemeyer P . Return to Sports Activity and Work After Autologous Chondrocyte Implantation of the Knee: Which Factors Influence Outcomes?. Am J Sports Med. 2015; 44(2):370-7. DOI: 10.1177/0363546515614578. View